Printer Friendly

Browse Bendamustine topic

Articles

1-62 out of 62 article(s)
Title Author Type Date Words
Abbvie Notes Positive Data For Leukemia Drugs Imbruvica And Venclexta. Dec 7, 2020 273
Roche Reports New Data Showing Long-Term Benefits Of New Drugs. Dec 7, 2020 180
AstraZeneca Says Calquence Secures EU Approval As Leukaemia Treatment. Nov 9, 2020 249
Genmab A/S to conduct Phase 3 study of epcoritamab in patients with relapsed or refractory DLBCL. Nov 5, 2020 184
Genmab A/S to conduct Phase 3 study of epcoritamab in patients with relapsed or refractory DLBCL. Nov 5, 2020 189
Genmab A/S to conduct Phase 3 study of epcoritamab in patients with relapsed or refractory DLBCL. Nov 5, 2020 188
Paraneoplastic Pemphigus Involving the Respiratory and Gastrointestinal Mucosae. Odani, Kentaro; Itoh, Akane; Yanagita, Soshi; Kaneko, Yasuhito; Tachibana, Mitsuhiro; Hashimoto, Tak Jul 31, 2020 3085
TOP NEWS: AstraZeneca And Daiichi Team For New Cancer Tumour Drug. Jul 27, 2020 604
Second Cancers in a Patient with Gastric MALT Lymphoma. Navsaria, Lucy; Badillo, Alfonso; Wang, Michael May 31, 2020 2543
HSV-1 Encephalitis in an Elderly Man Receiving Ibrutinib for Waldenstrom's Macroglobulinemia. Wallace, Mark R. Apr 30, 2020 1083
Novel medications approved in 2019. Briggs, Gerald G. Apr 1, 2020 2046
Eagle Pharmaceuticals' Japanese Licensing Partner SymBio Completes Clinical Trial Enrollment for Treakisym Rapid Infusion Liquid Bendamustine Formulation. Apr 1, 2020 304
Non-Nodal CD5-Negative Mantle Cell Lymphoma with Secondary TP53 Deletion. McCall, Robert K.; Pang, Changlee S.; Pettenati, Mark J. Mar 31, 2020 2899
Delayed Chylothorax during Treatment of Follicular Lymphoma with a Malignant Pleural Effusion. Ekeke, Chigozirim N.; Chan, Ernest G.; Luketich, James D.; Dhupar, Rajeev Mar 31, 2020 1556
Autophagy Inhibition Potentiates the Anticancer Effects of a Bendamustine Derivative NL-101 in Acute T Lymphocytic Leucemia. Gao, Hang; Lou, Siyue; Hong, Huanwu; Ge, Qiufu; Zhao, Huajun Mar 1, 2020 6437
European Medicines Agency Validates Kite's Marketing Application for company's Second CAR T Cell Therapy. Jan 30, 2020 608
Seattle announces milestone payment from Roche upon EC's conditional marketing authorisation for Polivy. Jan 22, 2020 225
Seattle announces milestone payment from Roche upon EC's conditional marketing authorisation for Polivy. Jan 22, 2020 221
European Commission approves Roche's Polivy for people with previously treated aggressive lymphoma. Jan 21, 2020 1589
European regulator receives Janssen Pharmaceutical application for Imbruvica (ibrutinib) in combination with rituximab approval. Jan 21, 2020 207
European regulator receives Janssen Pharmaceutical application for Imbruvica (ibrutinib) in combination with rituximab approval. Jan 21, 2020 203
European Commission Approves Roche's Polivy In Aggressive Lymphoma. Jan 21, 2020 320
CHMP recommends conditional EU approval of Roche's Polivy for people with previously treated aggressive lymphoma. Nov 15, 2019 1494
Symptomatic Hypoalbuminemia as an Indication for Treatment of Waldenstrom Macroglobulinemia: A Case Report and Review of the Literature. Larsen, Jeremy T.; Leonard, Frederick D. Oct 31, 2019 2836
Multiple Myeloma Treatment Market Size, Technology, Regional Scope, Growth Opportunity, Key Highlights, Demand and Trends, Forecast To 2023. Oct 18, 2019 929
Japan Pharmaceuticals - Eagle Pharmaceuticals' Japanese Licensing Partner SymBio Announces its Submission of a New Drug Application for TREAKISYM[R] Ready-To-Dilute Formulation -- 7/10/2019. Oct 16, 2019 519
Eagle Pharmaceuticals' Japanese Licensing Partner SymBio Submits a New Drug Application for Treakisym Ready-To-Dilute Formulation. Oct 11, 2019 262
Japan Pharmaceuticals - Eagle Pharmaceuticals' Japanese Licensing Partner SymBio Announces its Submission of a New Drug Application for TREAKISYM[R] Ready-To-Dilute Formulation -- 7/10/2019. Oct 8, 2019 519
Eagle Pharmaceuticals says SymBio submits NDA for TREAKISYM RTD. Oct 7, 2019 124
Waldenstrom Macroglobulinemia Market Projections Analyzed To Inspect Growth Trends during Forecast P. Sep 13, 2019 832
NavigaWaldenstrom Macroglobulinemia Market Projected to Augment at a Notable CAGR during the Forecas. Sep 12, 2019 903
Waldenstrom Macroglobulinemia Market Projections Analyzed To Inspect Growth Trends during Forecast P. Sep 12, 2019 846
NavigaWaldenstrom Macroglobulinemia Market Projected to Augment at a Notable CAGR during the Forecas. Sep 11, 2019 918
AstraZeneca - Calquence significantly prolonged the time patients lived without disease progression in relapsed or refractory chronic lymphocytic leukaemia -- 17/6/2019. Jun 18, 2019 407
AstraZeneca reports positive results from the interim analysis of the phase III ASCEND trial of Calquence. Jun 18, 2019 295
AstraZeneca announces results from interim analysis of Phase 2 ASCEND trial. Financial report Jun 16, 2019 194
Seattle Genetics Makes Multiple Adcetris Presentations at the Congress of the European Hematology Association and the International Conference on Malignant Lymphoma. Conference news Jun 14, 2019 363
Seattle Genetics (NASDAQ: SGEN) - Seattle Genetics' Antibody-Drug Conjugate Technology Utilized in Genentech's Polivy, Now Approved by FDA -- 10/6/2019. Jun 13, 2019 381
Genentech receives USFDA approval for Polivy combination. Jun 12, 2019 158
Genentech receives USFDA approval for Polivy combination. Jun 12, 2019 154
FDA Grants Genentech's Polivy Accelerated Approval for People with Previously Treated Aggressive Lymphoma. Jun 12, 2019 950
The US FDA approves the first chemoimmunotherapy regimen Polivy with BR for patients with relapsed or refractory diffuse large B-cell lymphoma. Jun 11, 2019 265
The US FDA approves the first chemoimmunotherapy regimen Polivy with BR for patients with relapsed or refractory diffuse large B-cell lymphoma. Jun 11, 2019 261
Roche Gets Accelerated Approval In US For Lymphoma Drug Polivy. Jun 11, 2019 333
FDA grants Genentech's Polivy accelerated approval in aggressive lymphoma. Jun 10, 2019 187
Seattle Genetics reports FDA approval of Polivy, says milestone triggered. Jun 10, 2019 172
AstraZeneca's Calquence phase III ASCEND trial meets primary endpoint. May 8, 2019 292
AstraZeneca's Calquence phase III ASCEND trial meets primary endpoint. May 8, 2019 288
AstraZeneca reports Calquence met primary endpoint in Phase 3 ASCEND trial. May 6, 2019 152
NavigaWaldenstrom Macroglobulinemia Market Prospects and Growth Assessment Presented Until the End o. Apr 24, 2019 817
DEGREE OF ASSOCIATION BETWEEN FLUDEOXYGLUCOSE UPTAKE IN PALATINE TONSILS IN PET SCAN AND HISTOPATHOLOGIC EXAMINATION IN FOLLOW UP CASES OF NON-HODGKIN'S LYMPHOMA AND HODGKIN'S LYMPHOMA. Singh, Sanajeet K.; Sameul, Sameer; Gupta, Devender K.; Roy, Ravi; Chugh, Rajeev; Goyai, Sunil; Dhak Apr 22, 2019 2020
Central Nervous System Involvement by Waldenstrom Macroglobulinemia: A Case Report of the Bing-Neel Syndrome. Arjunan, Ananth; Rai, Hema Mar 31, 2019 1802
Entecavir-Associated Thrombocytopenia: A Case Report and Review of the Pathophysiology, Diagnosis, and Treatment of a Rare but Reversible Cause of Thrombocytopenia. Yohannan, Binoy; Luu, Dai Chu N.; Feldman, Mark Mar 31, 2019 2543
Multiple Faces of Chronic Lymphocytic Leukaemia: A Patient with Renal, Cardiac, and Skeletal Complications. Htet, Zay Myo; Gomez, Cesar; Ali, Ahsan; Nair, Sunil; Karim, Mahzuz Mar 31, 2019 3131
MorphoSys--MorphoSys AG: MorphoSys Provides Updates on L-MIND and B-MIND Clinical Trials of MOR208 in Relapsed/Refractory DLBCL--7/3/2019. Mar 20, 2019 547
US FDA grants priority review to Roche's Entrectinib and polatuzumab vedotin. Feb 21, 2019 231
US FDA grants priority review to Roche's Entrectinib and polatuzumab vedotin. Feb 21, 2019 227
BENDAMUSTINE: AN OLD DRUG IN THE NEW ERA FOR PATIENTS WITH NON-HODGKIN LYMPHOMAS AND CHRONIC LYMPHOCYTIC LEUKEMIA. Patekar, Martina Bogeljic; Milunovic, Vibor; Jakobac, Karla Misura; Perica, Drazen; Rogulj, Inga Man Report Sep 1, 2018 8445
Composite t(14;18)-Negative Follicular Lymphoma and Nodular Lymphocyte-Predominant Hodgkin Lymphoma. O'Neill, John Patrick; Quinn, Fiona; Dowling, Anita; Walker, Jan; Hayes, Triona; Bird, Brian; Flavin Jan 1, 2018 2027
A Case of Bing-Neel Syndrome Successfully Treated with Ibrutinib. O'Neil, Daniel S.; Francescone, Mark A.; Khan, Karen; Bachir, Alobeid; O'Connor, Owen A.; Sawas, Ahm Jan 1, 2018 2600
Pulmonary Mucormycosis in Chronic Lymphocytic Leukemia and Neutropenia. Mir, Izza; Basnet, Sijan; Ellsworth, David; Mohanty, Elan Report Jan 1, 2018 1981
Chronic lymphocytic leukemia (CLL). Hoffman, E.J. Letter to the editor Aug 1, 2010 255

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters